184 related articles for article (PubMed ID: 24165483)
21. Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer.
Fang L; Yang Z; Zhou J; Tung JY; Hsiao CD; Wang L; Deng Y; Wang P; Wang J; Lee MH
Mol Cancer Ther; 2015 Jun; 14(6):1476-87. PubMed ID: 25855785
[TBL] [Abstract][Full Text] [Related]
22. RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses.
Dolly SO; Gurden MD; Drosopoulos K; Clarke P; de Bono J; Kaye S; Workman P; Linardopoulos S
Br J Cancer; 2017 Sep; 117(7):954-964. PubMed ID: 28829765
[TBL] [Abstract][Full Text] [Related]
23. Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells.
Yeh CH; Bellon M; Wang F; Zhang H; Fu L; Nicot C
Mol Cancer; 2020 Sep; 19(1):139. PubMed ID: 32907612
[TBL] [Abstract][Full Text] [Related]
24. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
[TBL] [Abstract][Full Text] [Related]
25. Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma.
Xu Y; Yu J; Liu T; Meng F; Kong D; Lou G
Biomarkers; 2016; 21(4):379-85. PubMed ID: 26954701
[TBL] [Abstract][Full Text] [Related]
26. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer.
Calcagno DQ; Freitas VM; Leal MF; de Souza CR; Demachki S; Montenegro R; Assumpção PP; Khayat AS; Smith Mde A; dos Santos AK; Burbano RR
BMC Gastroenterol; 2013 Sep; 13():141. PubMed ID: 24053468
[TBL] [Abstract][Full Text] [Related]
27. FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation.
Malyukova A; Brown S; Papa R; O'Brien R; Giles J; Trahair TN; Dalla Pozza L; Sutton R; Liu T; Haber M; Norris MD; Lock RB; Sangfelt O; Marshall GM
Leukemia; 2013 Apr; 27(5):1053-62. PubMed ID: 23228967
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer.
Akhoondi S; Lindström L; Widschwendter M; Corcoran M; Bergh J; Spruck C; Grandér D; Sangfelt O
Breast Cancer Res; 2010; 12(6):R105. PubMed ID: 21122106
[TBL] [Abstract][Full Text] [Related]
29. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
[TBL] [Abstract][Full Text] [Related]
30. FBXW7 mutation analysis and its correlation with clinicopathological features and prognosis in colorectal cancer patients.
Chang CC; Lin HH; Lin JK; Lin CC; Lan YT; Wang HS; Yang SH; Chen WS; Lin TC; Jiang JK; Chang SC
Int J Biol Markers; 2015 Feb; 30(1):e88-95. PubMed ID: 25450649
[TBL] [Abstract][Full Text] [Related]
31. Role of Fbxw7 expression in hepatocellular carcinoma and adjacent non-tumor liver tissue.
Imura S; Tovuu LO; Utsunomiya T; Morine Y; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Yamada S; Ishikawa D; Bando Y; Shimada M
J Gastroenterol Hepatol; 2014 Oct; 29(10):1822-9. PubMed ID: 24731221
[TBL] [Abstract][Full Text] [Related]
32. FBXW7 overexpression suppresses renal cancer cell proliferation and induces apoptosis.
Fu Y; Lin Y; Yang Z; Yang G; Li G; Liu Y; Tan X; Huang Y; Wu X; Wang Y; Xiong H; Zhang M; Fang L; Ge Y; Zeng J; Cai Y; Bai J; Wu S
Med Oncol; 2015 Aug; 32(8):215. PubMed ID: 26163148
[TBL] [Abstract][Full Text] [Related]
33. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
34. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
[TBL] [Abstract][Full Text] [Related]
35. miR‑223‑3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors.
Liu J; Shi H; Li X; Chen G; Larsson C; Lui WO
Int J Oncol; 2017 Feb; 50(2):356-364. PubMed ID: 28000896
[TBL] [Abstract][Full Text] [Related]
36. The FBXW7 beta-form is suppressed in human glioma cells.
Gu Z; Inomata K; Ishizawa K; Horii A
Biochem Biophys Res Commun; 2007 Mar; 354(4):992-8. PubMed ID: 17274947
[TBL] [Abstract][Full Text] [Related]
37. Sequential expression of miR-182 and miR-503 cooperatively targets FBXW7, contributing to the malignant transformation of colon adenoma to adenocarcinoma.
Li L; Sarver AL; Khatri R; Hajeri PB; Kamenev I; French AJ; Thibodeau SN; Steer CJ; Subramanian S
J Pathol; 2014 Dec; 234(4):488-501. PubMed ID: 25269767
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
Wertz IE; Kusam S; Lam C; Okamoto T; Sandoval W; Anderson DJ; Helgason E; Ernst JA; Eby M; Liu J; Belmont LD; Kaminker JS; O'Rourke KM; Pujara K; Kohli PB; Johnson AR; Chiu ML; Lill JR; Jackson PK; Fairbrother WJ; Seshagiri S; Ludlam MJ; Leong KG; Dueber EC; Maecker H; Huang DC; Dixit VM
Nature; 2011 Mar; 471(7336):110-4. PubMed ID: 21368834
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
[TBL] [Abstract][Full Text] [Related]
40. The Fbxw7/hCdc4 tumor suppressor in human cancer.
Tan Y; Sangfelt O; Spruck C
Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]